![Troy Lister](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Troy Lister
Corporate Officer/Principal at
American Chemical Society
Profile
Troy Lister currently works at American Chemical Society, as Member.
Dr. Lister also formerly worked at Spero Therapeutics, Inc., as Senior Vice President-Research & Development from 2014 to 2022 and Verve Therapeutics, Inc., as Chief Scientific Officer from 2024 to 2025.
Dr. Lister received his undergraduate degree and doctorate degree from Flinders University.
Troy Lister active positions
| Companies | Position | Start |
|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Corporate Officer/Principal | - |
Former positions of Troy Lister
| Companies | Position | End |
|---|---|---|
| VERE THER | Chief Tech/Sci/R&D Officer | 25/07/2025 |
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2022 |
Training of Troy Lister
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
Flinders University
 Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
- Stock Market
- Insiders
- Troy Lister
